ALLMedicine™ Glucose Intolerance Center

Jun 10th, 2021 - During the coronavirus disease 2019 pandemic, the Japanese Society of Diabetes and Pregnancy (JSDP) proposed the use of random plasma glucose and HbA1c measured 1 month after delivery combined with pre-pregnancy body mass index to detect postpartu...

Jun 6th, 2021 - Aryl hydrocarbon receptor (AhR) plays a role in xenobiotic metabolism, which can be also activated by dietary patterns and components. AhR ligands in circulation are reported to inducing weight gain, glucose intolerance, and suggested to contribut...

May 30th, 2021 - Assisted Reproductive Technologies (ART) allowed the births of >8 million babies worldwide. Even if ART children are healthy at birth, several studies reported that ART may cause changes in foetal programming, leading to an increased predispositio...

May 27th, 2021 - Patients with growth hormone (GH)-secreting adenoma usually develop glucose intolerance. GH increases metabolic rate and, when secreted aberrantly, may result in metabolic syndrome. Herein, we examine the associations of pituitary tumor-induced se...

May 23rd, 2021 - Obesity and other metabolic comorbidities affect over 10% of patients with breast cancer and are closely related with adverse outcomes. Although metabolic comorbidities among breast cancer patients in low- and middle-income countries are suggested...

Jul 30th, 2013 - Diabetes and glucose intolerance are common complications of chronic pancreatitis, yet clinical guidance on their detection, classification, and management is lacking. A working group reviewed the medical problems, diagnostic methods, and treatmen...

Jun 10th, 2021 - During the coronavirus disease 2019 pandemic, the Japanese Society of Diabetes and Pregnancy (JSDP) proposed the use of random plasma glucose and HbA1c measured 1 month after delivery combined with pre-pregnancy body mass index to detect postpartu...

Jun 6th, 2021 - Aryl hydrocarbon receptor (AhR) plays a role in xenobiotic metabolism, which can be also activated by dietary patterns and components. AhR ligands in circulation are reported to inducing weight gain, glucose intolerance, and suggested to contribut...

May 30th, 2021 - Assisted Reproductive Technologies (ART) allowed the births of >8 million babies worldwide. Even if ART children are healthy at birth, several studies reported that ART may cause changes in foetal programming, leading to an increased predispositio...

May 27th, 2021 - Patients with growth hormone (GH)-secreting adenoma usually develop glucose intolerance. GH increases metabolic rate and, when secreted aberrantly, may result in metabolic syndrome. Herein, we examine the associations of pituitary tumor-induced se...

May 23rd, 2021 - Obesity and other metabolic comorbidities affect over 10% of patients with breast cancer and are closely related with adverse outcomes. Although metabolic comorbidities among breast cancer patients in low- and middle-income countries are suggested...

Jan 28th, 2021 - Consuming the maximum acceptable daily intake of the noncaloric artificial sweetener saccharin for 2 weeks did not alter gut microbiota diversity or composition, or induce glucose intolerance, in 23 healthy young men and women. And consuming four ...

Jun 15th, 2020 - Eating a late dinner alters metabolic markers during sleep in a way that could lead to obesity or diabetes, according to the results of a small randomized crossover clinical trial, the Effect of Late Dinner on Nocturnal Metabolism. Specifically, 2...

Jun 15th, 2020 - Eating a late dinner alters metabolic markers during sleep in a way that could lead to obesity or diabetes, according to the results of a small randomized crossover clinical trial, the Effect of Late Dinner on Nocturnal Metabolism. Specifically, 2...

May 10th, 2020 - In April 2020, the Italian Society of Rheumatology published their recommendations for the management of patients with a diagnosis of polymyalgia rheumatica.[1] Pretreatment Evaluation All patients with clinically diagnosed polymyalgia rheumatica ...

Nov 24th, 2019 - Recovering from metabolic syndrome (MetS) lowers the risk for major adverse cardiovascular events (MACE), according to results of a nationwide cohort study published November 25 in Annals of Internal Medicine. Several investigations have associate...